UK Pro-Innovation Report Offers Promise For Medtech With MHRA/NICE Alignment

IDAP medtech innovation pathway set for launch in 2023

Report to government underlines need for faster, parallel evaluation of medtech and healthtech innovation and recommends bigger role for MHRA alongside work done by approved bodies on UKCA file processing.

Finger about to press a start button with the word innovation on the left.
• Source: Shutterstock

After a brief news lull around medtech regulatory system changes for the UK, the government and Medicines and Healthcare products Regulatory Agency (MHRA) issued several updates on new structures and access to medtech and healthtech in late May.

Among them was the government’s response to the chief scientific advisor’s (CSA) report on the pro-innovation regulation of emerging life...

More from United Kingdom

More from Europe